Font : A-A+

Drug information on Mibor (3.5mg) (Bortezomib) from Celon Laboratories Ltd.

Mibor (3.5mg)   Injection Celon Laboratories Ltd. Generic : Bortezomib	15,000.00 3.5mg/1vial 1Vial

Multiple Myeloma

•   Blood : Anemia, decrease in white blood cells and platelets.

•   Gastrointestinal : Nausea, diarrhea, constipation, vomiting, abdominal pain and indigestion.

•   Central Nervous System : Nerve disease, dizziness, headache, sleeplessness and tingling.

•   General : Fever, fatigue, weakness and swelling in the extremities.

•   Infections : Pneumonia and lung infection.

•   Musculoskeletal : Back pain, pain in extremities and joint pain.

•   Metabolic : Loss of appetite.

•   Skin : Rash and itching.

•   Respiratory : Cough and difficulty in breathing.

•   Heart : Low or high blood pressure.

Adult: IV- 1.3 mg/m² as bolus on days 1, 4, 8 and 11 of a 21-day cycle, followed by a 10-day rest period (days 12-21).

It comes as a solution for injection to be administered by a healthcare provider into the vein.

Hypersensitivity.

• Caution should be exercised in patients with history of heart disease, infection, sugar, fainting, high cholesterol, high or low blood pressure, weakness, alcoholism, kidney or liver disease, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause dizziness, drowsiness, lightheadedness or blurred vision, do not drive a car or operate machinery and get up slowly from bed while taking this medication.

Avoid excess dosage.

Store the medication as directed by your physician.